EGFR and glioblastoma: Kaplan–Meier survival and univariate analyses demonstrated that age, LANCL2 or EGFR amplification, and their co-amplification were significantly associated with decreased OS of GBM patients (n = 81), whereas gender was not a significant variable (Fig. 3H, I).